Proton beam radiation as salvage therapy for bilateral colorectal liver metastases not amenable to second-stage hepatectomy

Surgery (United States)

Volumn 161, Issue 6, 2017, Pages 1543-1548

  Colbert, Lauren E ^a   Cloyd, Jordan M ^a   Koay, Eugene J ^a   Crane, Christopher H ^b   Vauthey, Jean Nicolas ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAPECITABINE; CETUXIMAB; COBALT; FLUOROURACIL; FOLINIC ACID; MICROSPHERE; YTTRIUM 90;

ADULT; ARTICLE; ARTIFICIAL EMBOLIZATION; BIOLOGIC EQUIVALENT DOSE; BREATH HOLDING; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CASE REPORT; COLON ADENOCARCINOMA; COLONOSCOPY; COLORECTAL LIVER METASTASIS; COMPUTER ASSISTED TOMOGRAPHY; DEEP INSPIRATORY BREATH HOLD; EMBOLIZATION COIL; FATIGUE; HEMICOLECTOMY; HUMAN; HUMAN TISSUE; IMAGE GUIDED BIOPSY; LIVER BIOPSY; LIVER RESECTION; MALE; MIDDLE AGED; MULTIPLE CYCLE TREATMENT; PARTIAL HEPATECTOMY; PATHOLOGY; PHASE CONTRAST SIMULATION COMPUTED TOMOGRAPHY; PORTAL HYPERTENSION; PRIMARY TUMOR; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTON THERAPY; RADIATION DOSE; RADIOEMBOLIZATION; RESPIRATORY GATED IMAGING; SALVAGE THERAPY; SECOND STAGE HEPATECTOMY; SPLENOMEGALY; THROMBOCYTOPENIA; TREATMENT RESPONSE; WILD TYPE; X-RAY COMPUTED TOMOGRAPHY; AGED; CANCER STAGING; COLORECTAL NEOPLASMS; EPIDEMIOLOGY; FACTUAL DATABASE; FEMALE; FOLLOW UP; LIVER NEOPLASMS; MORTALITY; PATIENT SAFETY; PROCEDURES; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING SYSTEM; RISK ASSESSMENT; SECONDARY; SURVIVAL ANALYSIS; TERMINALLY ILL PATIENT; TREATMENT OUTCOME; TUMOR INVASION;

ADULT; AGED; COLORECTAL NEOPLASMS; DATABASES, FACTUAL; FEMALE; FOLLOW-UP STUDIES; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PATIENT SAFETY; PROTON THERAPY; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RISK ASSESSMENT; SALVAGE THERAPY; SAMPLING STUDIES; SURVIVAL ANALYSIS; TERMINALLY ILL; TREATMENT OUTCOME;

EID: 85019162210     PISSN: 00396060     EISSN: 15327361     Source Type: Journal    
DOI: 10.1016/j.surg.2016.11.034     Document Type: Article

References (11)

1. 1 Brouquet, A., Abdalla, E.K., Kopetz, S., et al. High survival rate after two-stage resection of advanced colorectal liver metastases: response-based selection and complete resection define outcome. J Clin Oncol 29 (2011), 1083–1090.
2. 2 Comito, T., Cozzi, L., Clerici, E., et al. Stereotactic Ablative Radiotherapy (SABR) in inoperable oligometastatic disease from colorectal cancer: a safe and effective approach. BMC Cancer, 14, 2014, 619.
3. 3 McGinn, C.J., Ten Haken, R.K., Ensminger, W.D., Walker, S., Wang, S., Lawrence, T.S., Treatment of intrahepatic cancers with radiation doses based on a normal tissue complication probability model. J Clin Oncol 16 (1998), 2246–2252.
4. 4 Hwang, S., Lee, S.G., Ko, G.Y., et al. Sequential preoperative ipsilateral hepatic vein embolization after portal vein embolization to induce further liver regeneration in patients with hepatobiliary malignancy. Ann Surg 249 (2009), 608–616.
5. 5 Simpson, A.L., Leal, J.N., Pugalenthi, A., et al. Chemotherapy-induced splenic volume increase is independently associated with major complications after hepatic resection for metastatic colorectal cancer. J Am Coll Surg 220 (2015), 271–280.
6. 6 Shindoh, J., Vauthey, J.N., Zimmitti, G., et al. Analysis of the efficacy of portal vein embolization for patients with extensive liver malignancy and very low future liver remnant volume, including a comparison with the associating liver partition with portal vein ligation for staged hepatectomy approach. J Am Coll Surg 217 (2013), 126–133 discussion 133-24.
7. 7 Tao, R., Krishnan, S., Bhosale, P.R., et al. Ablative radiotherapy doses lead to a substantial prolongation of survival in patients with inoperable intrahepatic cholangiocarcinoma: a retrospective dose response analysis. J Clin Oncol 34 (2016), 219–226.
8. 8 Crane, C.H., Koay, E.J., Solutions that enable ablative radiotherapy for large liver tumors: fractionated dose painting, simultaneous integrated protection, motion management, and computed tomography image guidance. Cancer 122 (2016), 1974–1986.
9. 9 Hong, T.S., Wo, J.Y., Yeap, B.Y., et al. Multi-institutional phase II study of high-dose hypofractionated proton beam therapy in patients with localized, unresectable hepatocellular carcinoma and intrahepatic cholangiocarcinoma. J Clin Oncol 34 (2016), 460–468.
10. 10 Wang, X., Krishnan, S., Zhang, X., et al. Proton radiotherapy for liver tumors: dosimetric advantages over photon plans. Med Dosim 33 (2008), 259–267.
11. 11 Hong, T.S., DeLaney, T.F., Mamon, H.J., et al. A prospective feasibility study of respiratory-gated proton beam therapy for liver tumors. Pract Radiat Oncol 4 (2014), 316–322.